Sun's Halol Site Faces FDA Action

Sun Pharmaceutical Industries’ Halol site has failed to make the compliance cut, bringing back unpleasant memories of protracted enforcement action some years ago by the US Food and Drug Administration. The key difference this time round, however, appears to be that the facility is now less critical to the Indian firm’s operations following concerted risk mitigation efforts over the years that included shifting products filings to alternative sites.